Skip to Main Content

Paper Details

JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition.
J Allergy Clin Immunol
49
2021
JAK, JAK and STAT genes, Janus kinase, STAT, STAT genes, genetic diseases, genetic syndromes, human, inflammatory and neoplastic conditions, lymphoproliferation, malignancy, patients, ruxolitinib, tofacitinib
Author NameAffiliation
Massimo GadinaNational Institute of Arthritis, National Institutes of Health
Massimo GadinaNational Institute of Arthritis, National Institutes of Health
John J O'SheaNational Institute of Arthritis, National Institutes of Health
John J O'SheaNational Institute of Arthritis, National Institutes of Health
  • 1 - 4

Datasets

Release 1.2